Wuhan Youngsen Biotech
Latest round
- Series A
Last raised
- Feb 2015
Total raised
- $3.3M
Investors
- 1
About Wuhan Youngsen Biotech
Founded in 2009 and based in Wuhan, China, Wuhan Youngsen Biotech is a medical equipment manufacturer that focuses on research, development, and production of artificial blood vessel products. It has 1,000 square meters of GMP-compliant clean plant. The company has 20 invention patents, and awards honors including the National High-Tech Enterprises. In 2017, It participated in the national key research and development plan project. In June 2020, its YSVG-S02 Artificial Blood Vessel program began clinical trials. Youngsen Biotech's products include the artificial blood vessel VASCULAR GRAFT and the pathway triple-layer bionic small-caliber artificial blood vessel. The products are based on the structure of the human body's arteries.
Who invested in Wuhan Youngsen Biotech
1 investor across 1 round
See all investors in Wuhan Youngsen Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 11, 2015
Amount
$3.3M
Investors
Questions about Wuhan Youngsen Biotech
Who invested in Wuhan Youngsen Biotech?
Wuhan Youngsen Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Wuhan Youngsen Biotech raised?
Wuhan Youngsen Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Wuhan Youngsen Biotech last raise money?
Wuhan Youngsen Biotech's most recent round on record is a Series A, in Feb 2015.
What does Wuhan Youngsen Biotech do?
Founded in 2009 and based in Wuhan, China, Wuhan Youngsen Biotech is a medical equipment manufacturer that focuses on research, development, and production of artificial blood vessel products.
Where is Wuhan Youngsen Biotech headquartered?
Wuhan Youngsen Biotech is headquartered in Wuhan, China.
Which VCs invest in companies like Wuhan Youngsen Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Wuhan Youngsen Biotech's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Wuhan Youngsen Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.